Join Cambia Grove Utah to discuss investment market trends!
Where is capital flowing and what types of health care innovations have received funding? What are the projections for 2020?
Cambia Grove Lunch & Learns, presented by Intermountain Health Ventures, Epic Ventures and Mountain Pacific Venture Fund is a series offering opportunities for entrepreneurs to network over lunch with subject matter experts while learning about high-value health care topics.
Lunch will be provided.
Nickolas Mark is a Director in the Business Development group at Intermountain Healthcare and leads a number of strategic partnerships and strategic initiatives around personalized medicine, wearables, behavioral health, healthcare IT and digital health. Previously, Nickolas held senior roles at an investment management firm. He has a deep background in transactional and financial services. Prior to that, Nickolas worked as a management consultant and served global organizations and fortune 500 companies across multiple industries.
Taylor Leavitt is CEO and President of Leavitt Equity Partners, an affiliated value-add private equity fund that seeks to invest capital into growth and lower mid-market opportunities that align with the firm’s core beliefs about the future of health care. Taylor also leads the Leavitt Partners Equity Practice which directs the management of the firm’s portfolio holdings, due diligence processes, and relationships with other private equity funds and financial institutions.
Taylor has led the firm’s equity and investment activities since inception, which include equity positions in more than a dozen companies, including HealthEquity, Independent Living Systems, Health Integrated, Cogent Healthcare, RSA Medical, and others.
In 2014, Taylor led the effort of launching Leavitt Equity Partners and successfully raised its first $100 million fund. LEP has made investments into growing health care companies in health information technology, value-based care, pharmacy services, population analytics, health diagnostics and rural medicine.
Prior to joining Leavitt Partners, Taylor worked for ZARS Pharma, a venture capital-funded pharmaceutical company engaged in corporate licensing and business development operations. While at ZARS, Taylor identified, negotiated, and executed strategic corporate transactions on a global basis, including merger and acquisitions, national and international product licenses, IP and technology licenses, and R&D alliances. Prior to ZARS Pharma, Taylor was a founding employee for the Park City Center for Public Policy. In other capacities, Taylor has worked with Epic Venture Capital, SAIC, and Keystone Global Investment LLC.
Taylor received a master’s degree in business administration from the UCLA Anderson School of Business with an emphasis in private equity and entrepreneurship. He graduated magna cum laude from Utah State University studying finance, economics, and international business.